Medical Condition News

RSS

Exercise may slow kidney function decline in kidney disease patients

Increased physical activity may slow kidney function decline in patients with kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The findings suggest that exercise could have a powerful effect on maintaining patients' health.

13 Dec 2013

Study: Immune cells outside the brain may regulate propensity to develop depression

A new study shows that immune cells outside the brain may regulate propensity to develop depression. The data were presented today at the American College of Neuropsychopharmacology Annual Meeting.

13 Dec 2013

University of Colorado medical school professor uncovers variant of NKH

People from around the country and the world turn to Johan Van Hove, MD, PhD, for advice on a rare metabolic disease known as NKH, which can disrupt the body in devastating and even deadly ways. Now, Van Hove, a University of Colorado medical school professor, has identified a new disease related to NKH, a finding that resolves previously baffling cases including the death of a Colorado girl.

13 Dec 2013

Boys who grow up in two-parent homes less likely to have high blood pressure as adults

In a study of African-American men, researchers from the National Institutes of Health found that boys who grew up in two-parent homes were less likely to have high blood pressure as adults compared to those raised by a single parent. Reported in the Dec. 12, 2013, issue of the journal Hypertension, this is the first study of an African-American population to document an association between childhood family living arrangements and blood pressure.

13 Dec 2013

Researchers develop first test to identify acute mountain sickness

The first test to identify acute mountain sickness has been developed by a team of researchers in Italy and France and is presented today at EuroEcho-Imaging 2013. The test could revolutionise trekking and climbing by predicting who will develop the potentially deadly condition so they can avoid high altitudes, ascend more gradually or take preventative medication.

12 Dec 2013

Retrophin signs agreement with Novartis for exclusive U.S. license for Syntocinon Nasal Spray

Retrophin, Inc. today announced that it has signed an agreement with Novartis Pharma AG for an exclusive U.S. license for Syntocinon Nasal Spray, the intranasal formulation of a synthetic version of the naturally occurring peptide hormone oxytocin, for an upfront payment of $5.0 million plus milestone payments and royalties.

12 Dec 2013

NLST data provides vital information to better understand the benefits, risks of lung cancer screening

Data from the National Lung Cancer Screening Trial—conducted by the American College of Radiology Imaging Network and National Cancer Institute Lung Screening Study—provided researchers the opportunity to investigate the probability that a cancer detected with screening low-dose computed tomography would not have progressed to become life threatening. The results of this investigation published online today in JAMA Internal Medicine suggest that up to 18 percent of the cancers detected by LDCT may not have progressed enough to affect patient health if left undetected.

12 Dec 2013

Researchers show biophysical factors that contribute to the strength of heartbeat

The heart maintains a careful balancing act; too soft and it won't pump blood, but too hard and it will overtax itself and stop entirely. There is an optimal amount of strain that a beating heart can generate and still beat at its usual rate, once per second.

12 Dec 2013

Study: Majority of obese pediatric patients satisfied with telehealth appointment

For youth dealing with obesity who need extra help losing weight, experts suggest a multidisciplinary approach in which care is provided by several health specialists.

12 Dec 2013

Cook Medical begins clinical study to evaluate removability of Evolution Esophageal Fully Covered Stent

Cook Medical has initiated a clinical study in the U.S. to evaluate the removability of a new Evolution Esophageal Fully Covered Stent. This is the first multicenter U.S. study to evaluate the possibility of removing a self-expanding metal stent after malignant and benign strictures have been treated. The stent design used in the study has been modified to accommodate retrieval.

12 Dec 2013

Combination therapy safe and active in follicular lymphoma

One drug attacks tumor cells directly, the other treats the immune system by taking the brakes off T cell response.

12 Dec 2013

Study shows that age and sleep deprivation induce cellular stress in pancreas

Sleep, or the lack of it, seems to affect just about every aspect of human physiology. Yet, the molecular pathways through which sleep deprivation wreaks its detrimental effects on the body remain poorly understood.

12 Dec 2013

Asia-Pacific Osteoporosis Meeting focuses on new strategies in the battle against osteoporosis

Today, one of the largest clinical bone events in the Asia-Pacific region opened at the Hong Kong Conference and Exhibition Centre, drawing close to 850 international delegates from over 60 countries. The IOF Regionals 4th Asia-Pacific Osteoporosis Meeting, which continues through to December 15, is organized by the International Osteoporosis Foundation in cooperation with the Hong Kong Osteoporosis Foundation and the Osteoporosis Society of Hong Kong.

12 Dec 2013

Researchers discover new therapeutic approach for hemophilia

Researchers at the UNC School of Medicine and the Medical College of Wisconsin found that a new kind of gene therapy led to a dramatic decline in bleeding events in dogs with naturally occurring hemophilia A, a serious and costly bleeding condition that affects about 50,000 people in the United States and millions more around the world.

12 Dec 2013

New reports demonstrate the effectiveness of modified T cells in treating blood-borne cancers

At the 2013 American Society of Hematology meeting in Dec. 2013, James Kochenderfer, M.D., investigator in the Experimental Transplantation and Immunology Branch, NCI, presented findings from two clinical trials evaluating the use of genetically modified immune system T cells as cancer therapy.

12 Dec 2013

Researchers see links between high levels of perfluorinated compounds in blood and diabetes

Perfluorinated compounds are environmental toxins that are found in fire extinguishing foam and water-repellent textiles and, for example. In a new study, a research team led from Uppsala University has seen links between high levels of perfluorinated compounds in the blood and diabetes.

12 Dec 2013

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

A range of studies highlighting late-breaking research advances in the understanding and treatment of blood cancers and bleeding disorders are being presented today during the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans.

12 Dec 2013

Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Platelet-rich plasma (PRP) has grabbed headlines in recent years for its role in helping some of sports' biggest stars return to play following injury -including golfer Tiger Woods, Super Bowl winner Hines Ward and NBA legend Kobe Bryant.

12 Dec 2013

Understanding long-term clinical stability in hemophilia patients living with HIV

People with the genetic blood clotting disorder hemophilia who have been infected with HIV for decades have an increased proportion of immune cells in their blood that specifically target HIV. This protective immune response helps chronically infected hemophilia patients survive, even during periods of HIV activity, according to a study published in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

12 Dec 2013

Study: Taxol and Herceptin highly effective for lower-risk breast cancer patients

A remarkable 98.7 percent of certain lower-risk breast cancer patients were cancer free for at least three years after taking a combination of the drugs Herceptin and Taxol, a study has found.

12 Dec 2013

Medical Condition News

Exercise may slow kidney function decline in kidney disease patients

Study: Immune cells outside the brain may regulate propensity to develop depression

University of Colorado medical school professor uncovers variant of NKH

Boys who grow up in two-parent homes less likely to have high blood pressure as adults

Researchers develop first test to identify acute mountain sickness

Retrophin signs agreement with Novartis for exclusive U.S. license for Syntocinon Nasal Spray

NLST data provides vital information to better understand the benefits, risks of lung cancer screening

Researchers show biophysical factors that contribute to the strength of heartbeat

Study: Majority of obese pediatric patients satisfied with telehealth appointment

Cook Medical begins clinical study to evaluate removability of Evolution Esophageal Fully Covered Stent

Combination therapy safe and active in follicular lymphoma

Study shows that age and sleep deprivation induce cellular stress in pancreas

Asia-Pacific Osteoporosis Meeting focuses on new strategies in the battle against osteoporosis

Researchers discover new therapeutic approach for hemophilia

New reports demonstrate the effectiveness of modified T cells in treating blood-borne cancers

Researchers see links between high levels of perfluorinated compounds in blood and diabetes

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

Research paper provides first evidence-based recommendations for using PRP in orthopaedic care

Understanding long-term clinical stability in hemophilia patients living with HIV

Study: Taxol and Herceptin highly effective for lower-risk breast cancer patients

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News